Table 1.
Characteristics of the survey respondents and their experience with ASPs.
| Characteristic * | Total (n = 202) | Residents (n = 105) | Specialists (n = 97) |
|---|---|---|---|
| Age, median (IQR) | 37 (30–46) | 30 (27–33) | 46 (40–53) |
| Gender | |||
| Male | 114 (56.4) | 50 (47.6) | 64 (66) |
| Female | 88 (43.6) | 55 (52.4) | 33 (34) |
| Specialty | |||
| Medical | 124 (61.4) | 76 (72.4) | 48 (49.5) |
| Surgical | 65 (32.2) | 29 (27.6) | 36 (37.1) |
| ICU | 13 (6.4) | 0 (0) | 13 (13.4) |
| Years of experience, median (IQR) | |||
| In residency | n/a | 4 (2–5) | n/a |
| Post-residency | n/a | n/a | 11 (5–19) |
| Previous experience with ASPs | |||
| Yes | 29 (14.4) | 9 (8.6) | 20 (20.6) |
| No | 173 (85.6) | 96 (91.4) | 77 (79.4) |
| Rate of patients with MDR Gram-negative infection under respondents’ care | |||
| Zero | 23 (11.4) | 14 (13.3) | 9 (9.3) |
| 1–4 cases/month | 120 (59.4) | 72 (68.6) | 48 (49.5) |
| 5–10 cases/month | 34 (16.8) | 13 (12.4) | 21 (21.6) |
| >10 cases/month | 25 (12.4) | 6 (5.7) | 19 (19.6) |
| Rate of ASP consultation for patients with MDR Gram-negative infection under respondents’ care | |||
| Zero | 29 (14.3) | 20 (19) | 9 (9.3) |
| 1–4 times/month | 125 (61.9) | 70 (66.7) | 55 (56.7) |
| 5–10 times/month | 40 (19.8) | 13 (12.4) | 27 (27.8) |
| >10 times/month | 8 (4) | 2 (1.9) | 6 (6.2) |
| Respondents’ adherence to ASP team recommendations | |||
| Never | 5 (2.5) | 5 (4.8) | 0 (0) |
| Rarely | 5 (2.5) | 1 (0.9) | 4 (4.1) |
| Sometimes | 32 (15.8) | 14 (13.3) | 18 (18.6) |
| Often | 67 (33.2) | 34 (32.4) | 33 (34) |
| Always | 93 (46) | 51 (48.6) | 42 (43.3) |
* All data are in n (%), unless otherwise indicated. ASPs: antimicrobial stewardship programmes; IQR: interquartile range; ICU: intensive care unit; n/a: not available; MDR: multidrug-resistant.